PRESS RELEASE Innovative drug for common heart condition (England) NICE is provisionally recommending novel heart failure drug sacubitril valsartan (Novartis) as an option for some people with heart failure. This guidance recommends the drug for treating chronic heart failure with reduced ejection fraction[i] in people with New York Heart Association class II to III symptoms[ii]…
